Prostate cancer decisions — 2022

The Board has remanded the claims for service connection for right eye condition, left eye condition, and prostate cancer due to inadequate development regarding the types of gas used during gas mask training.

The Board denied the Veteran's claim for service connection for prostate cancer as there is no current diagnosis of the condition and the evidence does not show a relationship to his military service or herbicide exposure.

The Board has remanded the Veteran's claims for prostate cancer, bilateral hearing loss, and glaucoma as secondary to cancer treatment due to potential exposure to toxins and herbicides during service. The VA is instructed to investigate the Veteran's reports of alleged exposure and schedule him for appropriate examinations.

The Veteran's diarrhea is a residual of radiation treatment for his service-connected prostate cancer.,His right and left lower extremity lymphedema are also residuals of his service-connected prostate cancer.

The Board has restored service connection for prostate cancer, which was previously severed due to a presumption of exposure at Camp Lejeune. The Veteran's private medical opinion supports the link between his prostate cancer and the chemical exposures at Camp Lejeune.

The Board has denied a higher disability rating for prostate cancer residuals and remanded the claim of service connection for a psychiatric disorder secondary to prostate cancer. The case is now REMANDED for further development.

The Board denied the Veteran's claims for service connection for prostate cancer, finding that there was no evidence of a causal relationship between his prostate cancer and exposure to contaminated water at Camp Lejeune or his service-connected kidney or bladder cancers.

The Veteran's service-connected PTSD and prostate cancer have rendered him unable to secure or maintain substantially gainful employment, effective from May 31, 2018.

The Board has decided to remand the Veteran's claims for service connection due to exposure to herbicide agents, including Agent Orange. The issues include prostate cancer, lung disability (asthma and allergic rhinitis), chloracne, and heart arrhythmia with pacemaker.

The Veteran's respiratory, kidney, heart, bladder, and prostate disorders are remanded for further evaluation due to exposure to toxic chemicals in service.

The Board granted an effective date of April 9, 2013 for a 100% rating for prostate cancer, finding that the Veteran's PSA level on that date indicated active disease. The previous reduction from 100% to 20% was not based on clear and unmistakable error.

The Board has remanded the case due to insufficient verification of in-service exposure and a need for an opinion regarding whether prostate cancer is related to those exposures.

The Veteran's appeal for a higher rating for prostate cancer and TDIU was denied. The prostate cancer residuals are rated at 60 percent, the maximum allowed under VA regulations.

The Veteran's prostate cancer residuals are rated at a 60 percent disability rating since May 9, 2008. The case is remanded for further evaluation of other service-connected conditions.

The Board has remanded the claims for prostate cancer, blood cancer (polycythemia vera), and lung cancer due to the need for additional medical opinions regarding the relationship between these conditions and service.

The Veteran's prostate cancer is granted on a presumptive basis due to herbicide exposure in Thailand. The issue of service connection for erectile dysfunction secondary to prostate cancer is remanded.

The Board has determined that the reduction of the disability rating for prostate cancer from 100 percent to 40 percent effective May 1, 2015 was proper based on evidence showing no recurrence or metastasis of the condition.

The Board has denied service connection for bilateral hearing loss and remanded the issue of service connection for prostate cancer due to herbicide exposure.

The Veteran's claim for service connection for chronic obstructive pulmonary disease (COPD) is dismissed as the Veteran withdrew his appeal.,Service connection for prostate cancer, including due to exposure to herbicides (Agent Orange), is granted. The Board finds that the Veteran was exposed to Agent Orange and grants presumptive service connection for prostate cancer.

The Board has granted service connection for bilateral pes planus and denied service connection for diabetes mellitus, prostate cancer, and high cholesterol. The decision on the issue of service connection for diabetes mellitus is based on a lack of evidence showing its onset within one year after separation from service.